Manulife (NYSE: MFC) confirms 2026 preferred share conversion options
Filing Impact
Filing Sentiment
Form Type
6-K/A
Rhea-AI Filing Summary
Manulife Financial Corporation filed an amended Form 6-K to replace a prior version and correct clerical errors, attaching an updated news release. The release states Manulife will not redeem its outstanding Series 3 and Series 4 Class 1 preferred shares on June 19, 2026, preserving investor holdings.
Holders of the 6,537,903 Series 3 Preferred Shares and 1,462,097 Series 4 Preferred Shares may elect to convert between the two series on a one-for-one basis on June 19, 2026, subject to minimum outstanding thresholds of 1,000,000 shares per series. Deadlines, automatic conversion conditions and future dividend reset dates and announcement timing are detailed for investors.
Positive
- None.
Negative
- None.
Key Figures
Series 3 preferred shares outstanding: 6,537,903 shares
Series 4 preferred shares outstanding: 1,462,097 shares
Conversion instruction deadline: June 4, 2026, 5:00 p.m.
+5 more
8 metrics
Series 3 preferred shares outstanding
6,537,903 shares
Non-cumulative Rate Reset Class 1 Shares Series 3 outstanding before June 19, 2026
Series 4 preferred shares outstanding
1,462,097 shares
Non-cumulative Floating Rate Class 1 Shares Series 4 outstanding before June 19, 2026
Conversion instruction deadline
June 4, 2026, 5:00 p.m.
Toronto time deadline for brokers to submit preferred share conversion instructions
Conversion effective date
June 19, 2026
Date when Series 3 and Series 4 preferred share conversions take effect
Series 3 reset period
June 20, 2026–June 19, 2031
Five-year dividend rate period for Series 3 Preferred Shares
Series 4 rate period
June 20, 2026–September 19, 2026
Three-month dividend rate period for Series 4 Preferred Shares
Minimum shares per series
1,000,000 shares
Threshold below which remaining shares of a series are automatically converted into the other series
Dividend rate announcement date
May 21, 2026
Date Manulife will announce new dividend rates for Series 3 and Series 4
Key Terms
Non-cumulative Rate Reset Class 1 Shares Series 3, Non-cumulative Floating Rate Class 1 Shares Series 4, Conversion Privileges, prospectus supplement, +2 more
6 terms
Conversion Privileges financial
"Manulife Financial announces Conversion Privileges for its Series 3 and Series 4 Class 1 Preferred Shares"
prospectus supplement regulatory
"subject to certain conditions described in the prospectus supplement dated March 7, 2011"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
Securities Act of 1933 regulatory
"not been and will not be registered in the United States under the United States Securities Act of 1933"
U.S. person regulatory
"to, or for the account or benefit of, a “U.S. person” (as defined in Regulation S under the Securities Act)"
A U.S. person is anyone or any entity treated as subject to U.S. rules for taxes, securities and other regulations — typically U.S. citizens, lawful permanent residents, people who live in the U.S. long-term, and companies, trusts or estates organized under U.S. law. It matters to investors because being classified as a U.S. person can determine what investments you may buy, what disclosures or reports are required, and which tax and compliance obligations apply, like a membership badge that decides which rulebook governs you.
FAQ
What does Manulife (MFC) disclose in this amended Form 6-K?
Manulife’s amended Form 6-K replaces an earlier version to fix clerical errors and reissues a news release about its preferred shares. It confirms no planned redemption of Series 3 and Series 4 Class 1 preferred shares on June 19, 2026, and outlines related conversion rights.
